Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Ann Pharm Fr ; 79(1): 36-43, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32871133

RESUMEN

OBJECTIVES: Currently, the global interests tend to take advantage of the plant world as a renewable source of a natural and effective molecule, to find an eco-friendly, cost-effective, and less toxic alternative to the current synthetic pesticide. In this context, the present research was carried out in an attempt to study the insecticidal activity of extracts and pigments derived from the green plant Spinacia oleracea and the green alga Ulva lactuca against the fruit fly Drosophila melanogaster as an alternative to chemical insecticide. METHODS: The toxicity of the aqueous, acetonic and ethanolic extracts as well as of the purified pigments (Chlorophylls and carotenoids) was determined by complementary in vivo tests (application by spraying oranges, toxicity by ingestion and repellent activity). Interestingly, each one of these methods corresponds to a specific mode of exposure. RESULTS: Results showed that acetone extracts, which are rich in green pigments, present the best insecticidal activities. On the other hand, the purified chlorophyllian pigments exhibited an interesting activity only by spraying method. Regarding the repellent activity, the aqueous extract of spinach displayed higher effectiveness. CONCLUSION: Our study suggests the potential of tested plant and algal extracts, as well as of chlorophyllian pigments, to provide a safer alternative way to the use of synthetic pesticides.


Asunto(s)
Drosophila melanogaster , Repelentes de Insectos , Insecticidas/toxicidad , Spinacia oleracea/química , Ulva/química , Acetona , Animales , Carotenoides/farmacología , Clorofila/farmacología , Etanol , Pigmentos Biológicos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Solventes , Agua
2.
J Eur Acad Dermatol Venereol ; 32 Suppl 2: 15-23, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29894577

RESUMEN

OBJECTIVE: Our main objective was to compare Cutibacterium acnes (C. acnes) skin colonisation in patients with mild to moderate acne versus healthy controls and secondly, to evaluate a Myrtacine® -based cream on C. acnes total population and antibioresistant Cutibacteria in patients with acne. METHODS: In 60 acne patients (Global Acne Severity Scale, GEA grades 2-3), of mean age 20 [15-30] years and in 24 age- and sex- matched healthy controls, forehead strips samplings were performed for microbiological analysis of comedones by colony forming unit (CFU) counts of global C. acnes and erythromycin (EryR) or clindamycin-resistant (ClnR) populations of Cutibacterium and determination of phylotypes by MALTI-TOF. Clinical evaluations of acne patients (GEA, lesion count, porphyrin fluorescence) were performed at baseline and after 56 days of twice-daily application of a Myrtacine® -based cream. RESULTS: We first showed (i) high and similar levels of C. acnes colonisation in superficial pilosebaceous follicles and detection of EryR and ClnR strains in both acne and control groups; (ii) different repartition of phylotypes in acne patients versus healthy control, with a predominance of phylotype IA in acne patients and a link between phylotype IA and erythromycin resistance. Besides, after treatment with the Myrtacine® -based cream in acne patients, there was no change in C. acnes total load, but a significant decrease of EryR Cutibacteria, reduced porphyrin production by C. acnes, a decrease in acne severity (GEA), associated with reduced retentional and inflammatory lesions. CONCLUSION: Cutibacterium acnes colonisation was not significantly different in acne versus control groups. Phylotype IA was predominant in acne patient and in EryR C. acnes. A Myrtacine® -based cream significantly reduced the level of EryR Cutibacteria in vivo and improved acne lesions.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Acné Vulgar/microbiología , Extractos Vegetales/uso terapéutico , Propionibacterium acnes/aislamiento & purificación , Adolescente , Adulto , Carga Bacteriana , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Propionibacterium acnes/clasificación , Índice de Severidad de la Enfermedad , Adulto Joven
3.
Ann Phys Rehabil Med ; 57(4): 213-27, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24745692

RESUMEN

OBJECTIVE: To determine whether the addition of spa therapy to home exercises provides any benefit over exercises and the usual treatment alone in the management of generalised osteoarthritis associated with knee osteoarthritis. METHODS: This study was a post-hoc subgroup analysis of our randomised multicentre trial (www.clinicaltrial.gov: NCT00348777). Participants who met the inclusion criteria of generalized osteoarthritis (Kellgren, American College of Rheumatology, or Dougados criteria) were extracted from the original randomised controlled trial. They had been randomised using Zelen randomisation. The treatment group received 18days of spa treatment in addition to a home exercise programme. Main outcome was number of patients achieving minimal clinically important improvement at six months (MCII) (≥-19.9mm on the VAS pain scale and/or ≥-9.1 points in a WOMAC function subscale), and no knee surgery. Secondary outcomes included the "patient acceptable symptom state" (PASS) defined as VAS pain ≤32.3mm and/or WOMAC function subscale ≤31 points. RESULTS: From the original 462 participants, 214 patients could be categorized as having generalised osteoarthritis. At sixth month, 182 (88 in control and 94 in SA group) patients, were analysed for the main criteria. MCII was observed more often in the spa group (n=52/94 vs. 38/88, P=0.010). There was no difference for the PASS (n=19/88 vs. 26/94, P=0.343). CONCLUSIONS: This study indicates that spa therapy with home exercises may be superior to home exercise alone in the management of patients with GOA associated with knee OA.


Asunto(s)
Balneología , Osteoartritis de la Rodilla/terapia , Anciano , Femenino , Humanos , Masculino , Masaje , Persona de Mediana Edad , Peloterapia , Resultado del Tratamiento
4.
J Appl Microbiol ; 116(4): 761-71, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24251548

RESUMEN

AIMS: To investigate the preventive effects of an original combination of a grape seed extract (GSE) with an amine fluoride (Fluorinol(®) ) on dental plaque formation and oxidative damage caused by oral bacteria. METHODS AND RESULTS: The antibacterial activity of the compounds was assessed using the broth macrodilution method, and their antiplaque activity was evaluated on a multispecies biofilm grown on saliva-coated hydroxyapatite discs. The effect on glucosyltransferases activity was analysed through reductions in the overall reaction and the quantity of insoluble glucan synthesized. The combination of 2000 µg ml(-1) of GSE with 10·2 mg ml(-1) of Fluorinol(®) significantly decreased the biofilm formation (up to 4·76 log10 of reduction) and inhibited by 97·4% the insoluble glucan synthesis by glucosyltransferases. The antioxidant activity of this combination, alone or incorporated into a formulated mouthwash (Eludril daily(®) ), was determined using the Trolox equivalent antioxidant capacity assay (TEAC), and both showed significantly greater antioxidant capacity than vitamin C. CONCLUSIONS: The GSE/Fluorinol(®) combination showed both a significant antiplaque activity and an important antioxidant capacity in vitro, without any bactericidal effects. SIGNIFICANCE AND IMPACT OF THE STUDY: This is, to our knowledge, the first report on the properties of an original combination of a polyphenolic extract with amine fluoride that could be used for the prevention of oral diseases and oxidative damage associated.


Asunto(s)
Antibacterianos/farmacología , Antioxidantes/farmacología , Biopelículas/efectos de los fármacos , Polifenoles/farmacología , Vitis/química , Adulto , Aminas/farmacología , Antibacterianos/química , Antioxidantes/química , Bacterias/efectos de los fármacos , Clorhexidina/análogos & derivados , Clorhexidina/farmacología , Placa Dental/microbiología , Placa Dental/prevención & control , Fluoruros/farmacología , Glucanos/biosíntesis , Glucosiltransferasas/antagonistas & inhibidores , Humanos , Antisépticos Bucales/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Semillas/química
5.
Ann Rheum Dis ; 69(4): 660-5, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19734131

RESUMEN

OBJECTIVE: To determine whether spa therapy, plus home exercises and usual medical treatment provides any benefit over exercises and usual treatment, in the management of knee osteoarthritis. METHODS: Large multicentre randomised prospective clinical trial of patients with knee osteoarthritis according to the American College of Rheumatology criteria, attending French spa resorts as outpatients between June 2006 and April 2007. Zelen randomisation was used so patients were ignorant of the other group and spa personnel were not told which patients were participating. The main endpoint criteria were patient self-assessed. All patients continued usual treatments and performed daily standardised home exercises. The spa therapy group also received 18 days of spa therapy (massages, showers, mud and pool sessions). MAIN ENDPOINT: The number of patients achieving minimal clinically important improvement (MCII) at 6 months, defined as > or =19.9 mm on the visual analogue pain scale and/or > or =9.1 points in a normalised Western Ontario and McMaster Universities osteoarthritis index function score and no knee surgery. RESULTS: The intention to treat analysis included 187 controls and 195 spa therapy patients. At 6 months, 99/195 (50.8%) spa group patients had MCII and 68/187 (36.4%) controls (chi(2)=8.05; df=1; p=0.005). However, no improvement in quality of life (Short Form 36) or patient acceptable symptom state was observed at 6 months. CONCLUSION: For patients with knee osteoarthritis a 3-week course of spa therapy together with home exercises and usual pharmacological treatments offers benefit after 6 months compared with exercises and usual treatment alone, and is well tolerated.


Asunto(s)
Balneología/métodos , Osteoartritis de la Rodilla/terapia , Anciano , Antiinflamatorios/uso terapéutico , Terapia Combinada , Métodos Epidemiológicos , Terapia por Ejercicio , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Satisfacción del Paciente , Resultado del Tratamiento
6.
J Nutr Health Aging ; 13(9): 797-806, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19812870

RESUMEN

According to the latest forecasts of the INSEE - Institut National de la Statistique et des Etudes Economiques (National Statistics and Economic Studies Institute), ageing of the French population will increase between 2005 and 2050: whereas 20.8% of the population living in continental France reached the age of 60 years or more in 2005, this proportion would be of 30.6% in 2035 and 31.9% in 2050. In 2050, 22.3 million persons will have reached the age of 60 years or more compared to 12.6 million in 2005, increasing by 80% in a 45-year period. In line with the actual age pyramid, ageing is unavoidable, as those who will reach 60 years of age in 2050 are already born (in 1989 or before). This expansion will be most important between 2006 and 2035, when the numerous "baby-boom" generations born between 1946 and 1975, will reach these ages. In future years, lifespan improvement will only emphasize this increase. Even if life expectancy stabilizes at the 2005 level, the number of seniors reaching 60 years or more would still increase to 50% between 2005 and 2050. This issue is identical in all countries of the European Union. Ageing is a major risk factor for dementia that will considerably worsen in the next years, if no curative therapies are found. Today, 25 million persons in the world suffer from Alzheimer's disease (AD). In France, it is estimated that 860,000 persons are affected and that 225,000 news cases are annually diagnosed. After 75 years of age, more than 20% of women and 13% of men are concerned. Forecasts for the coming years are frightening. Considering ageing of the population, the number of Alzheimer's disease cases should raise to 1.3 million in 2020 (20 patients for 1000 inhabitants) ant 2.1 million in 2040 (30 patients for 1000 inhabitants).


Asunto(s)
Enfermedad de Alzheimer/epidemiología , Enfermedad de Alzheimer/prevención & control , Balneología , Cuidadores/psicología , Cuidados Intermitentes/organización & administración , Apoyo Social , Anciano , Anciano de 80 o más Años , Envejecimiento/psicología , Ejercicio Físico/fisiología , Ejercicio Físico/psicología , Estudios de Factibilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estado Nutricional , Calidad de Vida , Cuidados Intermitentes/métodos , Estrés Psicológico/epidemiología , Estrés Psicológico/prevención & control
7.
Comb Chem High Throughput Screen ; 11(5): 370-81, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18537558

RESUMEN

Heterotrimeric G-proteins, comprising Galpha, Gbeta, and Ggamma subunits, are molecular switches that regulate numerous signaling pathways involved in cellular physiology. This characteristic is achieved by the adoption of two principal states: an inactive state in which GDP-bound Galpha is complexed with the Gbetagamma dimer, and an active state in which GTP-bound Galpha is freed of its Gbetagamma binding partner. Structural studies have illustrated the basis for the distinct conformations of these states which are regulated by alterations in three precise 'switch regions' of the Galpha subunit. Discrete differences in conformation between GDP- and GTP-bound Galpha underlie its nucleotide-dependent protein-protein interactions (e.g., with Gbetagamma/receptor and effectors, respectively) that are critical for maintaining their proper nucleotide cycling and signaling properties. Recently, several screening approaches have been used to identify peptide sequences capable of interacting with Galpha (and free Gbetagamma) in nucleotide-dependent fashions. These peptides have demonstrated applications in direct modulation of the nucleotide cycle, assessing the structural basis for aspects of Galpha and Gbetagamma signaling, and serving as biosensor tools in assays for Galpha activation including high throughput drug screening. In this review, we highlight some of the methods used for such discoveries and discuss the insights that can be gleaned from application of these identified peptides.


Asunto(s)
Proteínas de Unión al GTP Heterotriméricas/química , Proteínas de Unión al GTP Heterotriméricas/metabolismo , Péptidos/química , Péptidos/metabolismo , Transducción de Señal , Secuencia de Aminoácidos , Evaluación Preclínica de Medicamentos , Proteínas de Unión al GTP Heterotriméricas/genética , Datos de Secuencia Molecular , Sensibilidad y Especificidad
8.
Ann Readapt Med Phys ; 46(9): 565-77, 2003 Dec.
Artículo en Francés | MEDLINE | ID: mdl-14642668

RESUMEN

Analgesic electrotherapy is now based on more consistent scientific data; the biological action of the electric current, of the electromagnetic radiations and of the mechanical vibrations is better approached. But the randomized control trials still provide contradictory results concerning the analgesic efficiency of the cryotherapy, the TENS, the pulsed electro-magnetic fields, the ultrasound and laser therapy, the shock waves; iontophoresis, short waves, microwaves, infrasound vibrations are very few investigated. The analgesic electrotherapy cannot be recommended nor prohibited; physical agents represent only therapeutic options. On the basis of the scientific data and of their personal experience, the therapists can use them. More controlled clinical investigations of higher methodological levels are still required.


Asunto(s)
Analgesia/métodos , Crioterapia , Terapia por Estimulación Eléctrica , Terapia por Estimulación Eléctrica/efectos adversos , Terapia por Estimulación Eléctrica/métodos , Campos Electromagnéticos , Humanos , Terapia por Láser , Ensayos Clínicos Controlados Aleatorios como Asunto , Ultrasonido
9.
Can J Microbiol ; 47(1): 9-17, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15049444

RESUMEN

The growth inhibitory effect of Cymbopogon nardus (L.) W. Watson var. nurdus essential oil on Aspergillus niger (Van Tieghem) mycelium was determined on agar medium. The mycelium growth was completely inhibited at 800 mg/L. This concentration was found to be lethal under the test conditions. Essential oil at 400 mg/L caused growth inhibition of 80% after 4 days of incubation, and a delay in conidiation of 4 days compared with the control. Microscopic observations were carried out to determine the ultrastructural modifications of A. niger hyphae after treatment with C. nardus essential oil. The main change observed by transmission electron microscopy concerned the hyphal diameter and the hyphal wall, which appeared markedly thinner. These modifications in cytological structure might be caused by the interference of the essential oil with the enzymes responsible for wall synthesis which disturb normal growth. Moreover, the essential oil caused plasma membrane disruption and mitochondrial structure disorganization. The findings thus indicate the possibility of exploiting Cymbopogon nardus essential oil as an effective inhibitor of biodegrading and storage-contaminating fungi.


Asunto(s)
Aspergillus niger/efectos de los fármacos , Aspergillus niger/crecimiento & desarrollo , Cymbopogon/química , Aceites Volátiles/farmacología , Aceites de Plantas/farmacología , Antifúngicos/farmacología , Aspergillus niger/citología , Aspergillus niger/ultraestructura , Membrana Celular/efectos de los fármacos , Membrana Celular/ultraestructura , Pared Celular/efectos de los fármacos , Pared Celular/ultraestructura , Hifa/efectos de los fármacos , Hifa/ultraestructura , Pruebas de Sensibilidad Microbiana , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Morfogénesis/efectos de los fármacos , Micelio/efectos de los fármacos , Micelio/crecimiento & desarrollo , Aceites Volátiles/química , Aceites de Plantas/química
10.
Planta Med ; 62(3): 275-7, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8693045

RESUMEN

Some monoterpenes and their carbonylated products were evaluated for their antibacterial and antifungal properties. The carbonylation of tested monoterpenes was shown to increase the bacteriostatic and fungistatic activities specifically by the contact method. Concerning the killing effects, only (1R,2S,5R)-isopulegol, its carbonylated products, and (R)-carvone showed significant bactericidal activities, particularly against Enterococcus faecium and Escherichia coli above a concentration of 10 microliters/ml. A fungicidal efficiency of (1R,2S,5R)-isopulegol and (R)-carvone against Aspergillus niger was also noted. It seems that the presence of an oxygenated function in the framework increases the antimicrobial properties. However, monoterpenes were more active using a micro-atmosphere method.


Asunto(s)
Antiinfecciosos/farmacología , Bacterias/efectos de los fármacos , Terpenos/farmacología , Antibacterianos , Antifúngicos/farmacología , Aspergillus niger/efectos de los fármacos , Candida albicans/efectos de los fármacos , Enterococcus faecium/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Relación Estructura-Actividad
11.
Int J Immunopharmacol ; 15(2): 163-73, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8096833

RESUMEN

Several functions of polymorphonuclear cells (PMNs) require adhesion to occur. Various membrane proteins' functions such as CD18 (beta 2 chain of integrin), CD35 (CR1) and CD16 (F c gamma Receptor III) participate in adhesion. In vivo treatment with Ribomunyl (R), an immunomodulating agent, was shown to enhance adhesion and migration of PMNs. To explore the direct effect of R on PMNs, cells from healthy subjects were treated in vitro with R. A significant increase of PMN adhesion and expression of CD18 and CD35 molecules were observed with 50 and 100 micrograms/ml of R after 2 h incubation. However, R-treatment decreased the PMN reactivity towards anti-CD16 (F c gamma RIII) monoclonal antibody. The effect of R on adhesion and membrane molecule expression was independent of the presence of serum and of polymixin B. Thus, this effect cannot be due to lipopolysaccharide (LPS) contaminants and does not require interactions with serum components. In previous studies, it was shown that in vitro amoxicillin increased some PMN functions whereas josamycin decreased them. The in vitro incubation of PMNs with R and amoxicillin (100 micrograms/ml) potentiated the positive effect of amoxicillin on adhesion and the antibiotic counterbalanced the negative effect of R on CD16 expression. In addition, R compensated the negative effect of josamycin (100 micrograms/ml) on PMN adhesion and on CD18 and CD35 expression. This study indicates: (1) the direct effect of R on PMN adhesion and on expression of molecules involved in adhesive-mediated functions, and (2) the beneficial effect of the association of R with antibiotics which can stimulate PMN activity.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Antibacterianos/administración & dosificación , Antígenos Bacterianos/administración & dosificación , Neutrófilos/efectos de los fármacos , Adulto , Amoxicilina/administración & dosificación , Antígenos CD/metabolismo , Antígenos CD18 , Adhesión Celular/efectos de los fármacos , Humanos , Técnicas In Vitro , Josamicina/administración & dosificación , Neutrófilos/citología , Neutrófilos/inmunología , Receptores de Complemento 3b/metabolismo , Receptores de IgG/metabolismo
12.
J Parodontol ; 10(4): 381-7, 1991 Nov.
Artículo en Francés | MEDLINE | ID: mdl-1811047

RESUMEN

Bactericidal activities of five mouthrinses containing cetylpyridinium chloride, hexetidine or chlorhexidine have been tested in vitro, against the main microorganisms involved in buccal affections. Mouthrinses containing hexetidine or chlorhexidine are effective, but chlorhexidine activity appears more extensive and homogeneous.


Asunto(s)
Antiinfecciosos Locales/farmacología , Bacterias/efectos de los fármacos , Boca/microbiología , Antisépticos Bucales/uso terapéutico , Cetilpiridinio/farmacología , Clorhexidina/farmacología , Hexetidina/farmacología , Pruebas de Sensibilidad Microbiana
13.
Int J Immunopharmacol ; 13(8): 1051-7, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1814845

RESUMEN

The in vivo effect of immunostimulant treatment, bacterial ribosomes together with membranal proteoglycans (three tablets and three sprays daily during 4 days) in combination or not with in vitro amoxicillin or josamycin (range 5-50 micrograms/ml), has been studied on three related functions of polymorphonuclear cells (PMN) isolated from human blood: adhesion, spontaneous and oriented migration. The immunostimulant treatment always induces an increase of the three parameters. A positive effect of high concentrations of amoxicillin could be also observed on adhesion and gives rise to a great additional impact by associating it with immunostimulant treatment (control: 8.26 PMN/field; assay: 51.55 PMN/field). Spontaneous and oriented migration are not very altered by in vitro antibiotics. A very significant decrease of chemotaxis has been only observed with 50 microgram/ml of josamycin. However, the immunostimulant treatment compensates for this negative effect. The real increase in PMN activation produced by the immunostimulant treatment might extend its indications beyond prevention during antibiotherapy, for example in the acute phase of respiratory infections.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Antibacterianos/farmacología , Neutrófilos/inmunología , Adulto , Amoxicilina/farmacología , Antígenos Bacterianos/administración & dosificación , Adhesión Celular/efectos de los fármacos , Adhesión Celular/inmunología , Movimiento Celular/efectos de los fármacos , Movimiento Celular/inmunología , Quimiotaxis de Leucocito/efectos de los fármacos , Quimiotaxis de Leucocito/inmunología , Femenino , Humanos , Técnicas In Vitro , Josamicina/farmacología , Masculino , Persona de Mediana Edad , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA